Aiming higher to achieve lower MR grades: Edwards PASCAL Transcatheter Valve Repair System

Learn about mitral regurgitation (MR) treatment, evidence and experiences from interventional cardiologist experts in mitral valve repair.


Bernard Prendergast
Guy’s and St Thomas’ Trust, London, England

Federico De Marco
IRCCS Policlinico San Donato - San Donato Milanese, Italy

Peter Lüdike
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, Essen, Germany

Seung-Beom Yi
Edwards Lifesciences, Irvine, California, USA

Philipp Lurz
University Heart Centre Leipzig, Leipzig, Germany

Jörg Hausleiter
Ludwig-Maximilians-Universität, Munich, Germany

Symposium highlights

Residual MR matters:
the significance of MR 0-1+

PASCAL repair system
and clinical program update

Interactive recorded case:
mixed FMR/DMR patient

Interactive recorded case: FMR patient

PASCAL implant design and R&D technology

Full-length symposium

Symposium objectives

  1. Examine the importance of achieving lower residual MR grades
  2. Explore the R&D technical background of the PASCAL repair system
  3. Review clinical data update from the CLASP Study and new trials/registries
  4. Discuss and interact during recorded case presentations of MR patients treated with the PASCAL repair system to explore various treatment strategies

Learn more about Edwards Lifesciences’ transcatheter mitral and tricuspid product portfolio

PASCAL repair system for mitral regurgitation

Learn more

PASCAL repair system for tricuspid regurgitation

Learn more
Get to know all of our transformational mitral and tricuspid therapies

Learn more

Cardioband tricuspid system

Learn more

Cardioband mitral system

Learn more

Stay up to date with mitral and tricuspid therapies

Sign up now to receive event and news information from Edwards Lifesciences including:

  • Publications
  • Congress highlights
  • Webinar invites
  • Product announcements and updates

heading 3

Content goes here